These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 4527026

  • 21. Is it chronic idiopathic myelofibrosis, myelofibrosis with myeloid metaplasia, chronic megakaryocytic-granulocytic myelosis, or chronic megakaryocytic leukemia? Further thoughts on the nosology of the clonal myeloid disorders.
    Lichtman MA.
    Leukemia; 2005 Jul; 19(7):1139-41. PubMed ID: 15902283
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Chronic myeloproliferative diseases].
    Verh Dtsch Ges Pathol; 1983 Jul; 67():214-75. PubMed ID: 6666266
    [No Abstract] [Full Text] [Related]

  • 25. Diagnosis and management of myeloproliferative disorders.
    Laszlo J, Huang AT.
    Curr Probl Cancer; 1977 Jul; 2(1):1-42. PubMed ID: 268266
    [No Abstract] [Full Text] [Related]

  • 26. [Primary and secondary thrombocythemia: apropos of 39 cases].
    Bernadou A, Loo H, Prost RJ, Doumenc J, Zittoun R, Bilski-Pasquier G.
    Sem Hop; 1968 Jun 26; 44(31):2092-100. PubMed ID: 4300454
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Cytogenetic studies in the chronic myeloproliferative syndrome.
    Kiossoglou KA, Mitus WJ, Dameshek W.
    Blood; 1966 Aug 26; 28(2):241-52. PubMed ID: 5222584
    [No Abstract] [Full Text] [Related]

  • 29. Aberrant expression of transforming growth factor beta-1 (TGF beta-1) per se does not discriminate fibrotic from non-fibrotic chronic myeloproliferative disorders.
    Bock O, Loch G, Schade U, von Wasielewski R, Schlué J, Kreipe H.
    J Pathol; 2005 Apr 26; 205(5):548-57. PubMed ID: 15726648
    [Abstract] [Full Text] [Related]

  • 30. Patho-anatomical features of the bone marrow.
    Lennert K, Nagai K, Schwarze EW.
    Clin Haematol; 1975 Jun 26; 4(2):331-51. PubMed ID: 1102191
    [No Abstract] [Full Text] [Related]

  • 31. [Difficulties in the diagnosis of myelosclerosis with myeloid metaplasia].
    Buligescu L.
    Med Interna (Bucur); 1968 Jun 26; 20(6):739-45. PubMed ID: 5258927
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Myelofibrosis--what's in a name? Consensus on definition and EUMNET grading.
    Thiele J, Kvasnicka HM.
    Pathobiology; 2007 Jun 26; 74(2):89-96. PubMed ID: 17587880
    [Abstract] [Full Text] [Related]

  • 34. Development of polycythemia vera in a patient with myeloid metaplasia and myelofibrosis. Report of a case with a comment on its significance in relation to prevailing views on myeloid metaplasia.
    Hershko C, Polliack A.
    Isr J Med Sci; 1971 Feb 26; 7(2):315-20. PubMed ID: 5560987
    [No Abstract] [Full Text] [Related]

  • 35. Transitions among the myeloproliferative disorders.
    Glasser RM, Walker RI.
    Ann Intern Med; 1969 Aug 26; 71(2):285-307. PubMed ID: 5257058
    [No Abstract] [Full Text] [Related]

  • 36. Definition, clinical features and diagnosis of polycythaemia vera.
    Gilbert HS.
    Clin Haematol; 1975 Jun 26; 4(2):263-90. PubMed ID: 1102188
    [No Abstract] [Full Text] [Related]

  • 37. The differential diagnostic significance of bone-marrow biopsy in haemoblastoses.
    Nagy G, Krasznai G, Léhi M, Szegedi J.
    Acta Morphol Acad Sci Hung; 1973 Jun 26; 21(1):79-88. PubMed ID: 4517967
    [No Abstract] [Full Text] [Related]

  • 38. [The treatment of myeloproliferative syndromes].
    Maurice P.
    Schweiz Med Wochenschr; 1975 Oct 04; 105(40):1269-74. PubMed ID: 1061995
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.